Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Nautilus Biotechnology Inc NAUT

Healthcare Advertising Agencies Biotechnology
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprising instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution... see more

Current News (NDAQ:NAUT)

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

GlobeNewswire November 3, 2025

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

GlobeNewswire October 28, 2025

Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025

GlobeNewswire October 7, 2025

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

GlobeNewswire August 27, 2025

Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

GlobeNewswire July 31, 2025

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

GlobeNewswire July 30, 2025

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

GlobeNewswire July 15, 2025

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

GlobeNewswire May 27, 2025

Nautilus Biotechnology Reports First Quarter 2025 Financial Results

GlobeNewswire April 29, 2025
View More News ››

Opinion & Analysis (NDAQ:NAUT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NAUT)

Nautilus Biotechnology (NAUT): Pioneering the Next Generatio

Interesting play in proteomics. NAUT looks promising but still early stage. Burning through cash at ~$50M annually but has $221M runway...
MikeTester - January 23, 2025

Nautilus Biotechnology: Pioneering a Revolutionary Proteomic

http://beyondspx.com/2024/08/02/nautilus-biotechnology-pioneering-a-revolutionary-proteomics-platform/
MikeTester - August 3, 2024
View more Bullboard ››

AKITA Drilling Ltd.

AKITA Drilling Ltd.

AKITA Drilling Ltd. operates as an oil and gas drilling contractor in Canada and the United States. It is involved in the ...
View More »